Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2020-06-22 Call Transcript
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification addressed to stock exchanges about an upcoming earnings conference call scheduled for June 26, 2020, to discuss the company's quarterly and annual financial results. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document does not contain actual financial data or detailed financial analysis but serves as an announcement of the earnings call event. Therefore, it is not an Earnings Release (ER) itself, nor an Interim/Quarterly Report (IR). Given the nature of the document as an announcement of an earnings conference call, the appropriate classification is Call Transcript (CT), as it pertains to the earnings call event, although the transcript itself is not included, this is the closest relevant category for an earnings call notification. Confidence is high due to clear references to the earnings call and regulatory context.
2020-06-22 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document text is extremely short (133 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any textual information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement of a report. According to the rules, such minimal or empty content defaults to Regulatory Filings (RNS) as a fallback category.
2020-06-15 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, providing an update on the impact of the COVID-19 pandemic on the company's operations. It is addressed to stock exchanges and discusses operational impacts, safety measures, and financial conditions but does not contain detailed financial statements or comprehensive financial analysis. The document is a regulatory announcement about business impact and compliance rather than a full financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure without substantive financial data or report content.
2020-05-28 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the approval of further investment by the company into its subsidiary by acquiring new equity shares under a Rights Issue. It details the transaction specifics, including the nature of the acquisition, shareholding percentages, and background of the acquired entity. This type of document is an update on capital structure changes and financing activities rather than a full financial report or earnings release. The document length is 3744 characters, which is relatively short and focused on a specific capital transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2020-05-19 English
Updates
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialised/rematerialised for the quarter ended 31 March 2020. It is addressed to stock exchanges and signed by the company secretary and compliance officer. The content is a compliance certificate confirming regulatory requirements related to securities processing, not a financial report or announcement of financial results. It is primarily an officer certification letter related to regulatory compliance. Therefore, it fits the category of Regulatory Filings (RNS) rather than a financial report or other specific filing type.
2020-05-06 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a collaboration between IIT Guwahati and Hester Biosciences Limited to develop a COVID-19 vaccine. It contains no financial data, regulatory filings, or corporate governance information. It is not a report, transcript, or announcement related to shareholder meetings, financial results, or capital changes. The content is informational and promotional about a research collaboration and vaccine development progress. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement or press release that does not fit other specific categories.
2020-04-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.